Details for 2021176545
Up to date per 03.04.2026
Actions
Details for 2021176545
Granted/Registered
European Patent
24.11.2021 A
05.10.2022 B1
13.02.2009
US
207890 P
A61K 47/68 20170101AFI20220704BHEP
Owner
Immunomedics, Inc.c/o Gilead Sciences, Inc., 333 Lakeside Drive Foster City, CA 94404US
Representative
Representative
Patentanwalt Keschmann GmbHRiemergasse 141010 WienAT
Inventor
GOVINDAN, Serengulam Morris Plains, 07950US
MOON, Sung-Ju Morris Plains, 07950US
GOLDENBERG, David M Morris Plains, 07950US
Information about Fees